Literature DB >> 3373682

A clinician's guide to the office measurement of cholesterol.

J J Burke1, P M Fischer.   

Abstract

The office laboratory has the potential to be an ideal setting for cholesterol testing if accurate test results are achieved. This study describes the performance of three office chemistry analyzers (Abbott Vision, Boehringer-Mannheim Reflotron, and Kodak Ektachem DT60 Analyzer) in the measurement of cholesterol. The accuracy of these instruments was assessed by testing aliquots of 84 plasma specimens and comparing these results with values obtained in one of the National Heart, Lung, and Blood Institute's Lipid Research Clinic laboratories. To evaluate instrument precision, results from each of the three instruments were compared with the cholesterol standards recently released by the College of American Pathologists. When operated according to the manufacturers' recommended procedures, each of the three instruments demonstrated analytic capabilities that met the current accuracy and precision goals established by the National Cholesterol Education Program. Analytic issues that are pertinent to the clinician's role as both the office laboratory director and the test interpreter are reviewed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3373682

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  10 in total

1.  Performance of the Reflotron in Massachusetts' Model System for Blood Cholesterol Screening Program.

Authors:  S Havas; R Bishop; L Koumjian; J Reisman; S Wozenski
Journal:  Am J Public Health       Date:  1992-03       Impact factor: 9.308

2.  Consensus on cholesterol.

Authors:  J Hammond; R J Rona
Journal:  BMJ       Date:  1991-05-18

3.  Precision and accuracy of a portable blood analyzer system during cholesterol screening.

Authors:  P Greenland; N L Bowley; C A French; B Meiklejohn; S Gagliano; C E Sparks
Journal:  Am J Public Health       Date:  1990-02       Impact factor: 9.308

4.  Aggressiveness, dominance, developmental factors, and serum cholesterol level in college males.

Authors:  R E Greene; B K Houston; S A Holleran
Journal:  J Behav Med       Date:  1995-12

5.  Detecting Elevated Cholesterol Levels: Part 1: How accurate is the Reflotron?

Authors:  H L Reimer; R W Elford; S Shumak
Journal:  Can Fam Physician       Date:  1991-11       Impact factor: 3.275

6.  Cholesterol reduction in the workplace and in community settings.

Authors:  M G Wilson
Journal:  J Community Health       Date:  1991-02

7.  Out-of-laboratory measurement of the blood cholesterol level. Canadian Society of Clinical Chemists Task Force on Out-of-Laboratory Blood Cholesterol Measurement.

Authors: 
Journal:  CMAJ       Date:  1990-10-15       Impact factor: 8.262

8.  Training health professionals and lay volunteers to deliver cholesterol screening and education programs.

Authors:  L A Linnan; K M Gans; M L Hixson; E Mendes; H Longpre; R A Carleton
Journal:  Public Health Rep       Date:  1990 Nov-Dec       Impact factor: 2.792

9.  Improvements in heart health behaviors and reduction in coronary artery disease risk factors in urban teenaged girls through a school-based intervention: the PATH program.

Authors:  Marcia Bayne-Smith; Paul S Fardy; Ann Azzollini; John Magel; Kathryn H Schmitz; Denise Agin
Journal:  Am J Public Health       Date:  2004-09       Impact factor: 9.308

10.  Coeur en santé St-Henri--a heart health promotion programme in a low income, low education neighbourhood in Montreal, Canada: theoretical model and early field experience.

Authors:  G Paradis; J O'Loughlin; M Elliott; P Masson; L Renaud; G Sacks-Silver; G Lampron
Journal:  J Epidemiol Community Health       Date:  1995-10       Impact factor: 3.710

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.